|
⚲
|
| Keyboard |
| Column Group IV GP LP
✚
|
|
|---|---|
| CIK # | 0001796356 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001796356] | |
| 4 | [0001796356] | |
| SC 13D | [0001796356] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Column Group IV GP LP | Eikon Therapeutics Inc | [2026-02-12] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Eikon Therapeutics Inc EIKN
Common Stock
|
2026-02-06 | Buy | 630,881 | $18.00 | 11,355,858 |
|
Eikon Therapeutics Inc EIKN
Series A-1 Preferred Stock · derivative
|
2026-02-06 | Conversion | 10,467,526 | ||
|
Eikon Therapeutics Inc EIKN
Series A Preferred Stock · derivative
|
2026-02-06 | Conversion | 330,000 | ||
|
Eikon Therapeutics Inc EIKN
Series C-1 Preferred Stock · derivative
|
2026-02-06 | Conversion | 827,278 | ||
|
Eikon Therapeutics Inc EIKN
Series A-1 Preferred Stock · derivative
|
2026-02-06 | Conversion | 357,216 | ||
|
Eikon Therapeutics Inc EIKN
Series A Preferred Stock · derivative
|
2026-02-06 | Conversion | 9,670,000 | ||
|
Eikon Therapeutics Inc EIKN
Series C-1 Preferred Stock · derivative
|
2026-02-06 | Conversion | 28,229 | ||
|
Eikon Therapeutics Inc EIKN
Series D Preferred Stock · derivative
|
2026-02-06 | Conversion | 5,133,076 | ||
|
Eikon Therapeutics Inc EIKN
Common Stock
|
2026-02-06 | Conversion | 47,898 | ||
|
Eikon Therapeutics Inc EIKN
Common Stock
|
2026-02-06 | Conversion | 44,249 | ||
|
Eikon Therapeutics Inc EIKN
Common Stock
|
2026-02-06 | Conversion | 110,928 | ||
|
Eikon Therapeutics Inc EIKN
Common Stock
|
2026-02-06 | Conversion | 1,403,568 | ||
|
Eikon Therapeutics Inc EIKN
Common Stock
|
2026-02-06 | Conversion | 1,296,629 | ||
|
Eikon Therapeutics Inc EIKN
Common Stock
|
2026-02-06 | Buy | 1,437,323 | $18.00 | 25,871,814 |
|
Eikon Therapeutics Inc EIKN
Common Stock
|
2026-02-06 | Buy | 49,556 | $18.00 | 892,008 |
|
Eikon Therapeutics Inc EIKN
Common Stock
|
2026-02-06 | Conversion | 3,785 | ||
|
Eikon Therapeutics Inc EIKN
Common Stock
|
2026-02-06 | Conversion | 688,283 | ||
|
RAPT Therapeutics Inc RAPT
Common Stock
|
2024-12-23 | Other | 1,352,008 | ||
|
RAPT Therapeutics Inc RAPT
Warrant (right to purchase) · derivative
|
2024-12-23 | Other | 1,352,008 | ||
|
RAPT Therapeutics Inc RAPT
Warrant (right to purchase) · derivative
|
2024-12-23 | Other | 1,599,417 | ||
| showing 20 of 105 most recent transactions | |||||